ARCHIVES

ImClone Protocol Generates More Questions Than Answers

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

NCABP “Anyone With Same Facts Would Have Come To Same Conclusion

October 28, 1994

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Bernard Fisher Sues Univ. of Pittsburgh And Its Attorney

July 15, 1994

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013